These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36868257)

  • 1. Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.
    Rubin DH; Mortimer TD; Grad YH
    Lancet Microbe; 2023 Apr; 4(4):e247-e254. PubMed ID: 36868257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.
    Golparian D; Jacobsson S; Sánchez-Busó L; Bazzo ML; Lan PT; Galarza P; Ohnishi M; Unemo M
    J Antimicrob Chemother; 2022 Dec; 78(1):150-154. PubMed ID: 36308328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility Trends of Zoliflodacin against Multidrug-Resistant
    Le W; Su X; Lou X; Li X; Gong X; Wang B; Genco CA; Mueller JP; Rice PA
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring quinolone resistance-determining region in
    Sood S; Agarwal M; Bala M; Mahajan N; Singh R; Kapil A; Sreenivas V; Ram RJ; Kar HK; Sharma VK;
    Indian J Med Res; 2017 Jul; 146(Supplement):S64-S69. PubMed ID: 29205198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    Unemo M; Ahlstrand J; Sánchez-Busó L; Day M; Aanensen D; Golparian D; Jacobsson S; Cole MJ;
    J Antimicrob Chemother; 2021 Apr; 76(5):1221-1228. PubMed ID: 33564854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.
    David A; Golparian D; Jacobsson S; Stratton C; Lan PT; Shimuta K; Sonnenberg P; Field N; Ohnishi M; Davies C; Unemo M
    J Antimicrob Chemother; 2024 Sep; 79(9):2221-2226. PubMed ID: 39004438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
    Ng LK; Sawatzky P; Martin IE; Booth S
    Sex Transm Dis; 2002 Dec; 29(12):780-8. PubMed ID: 12466720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U; Ray K; Bala M; Saluja D
    Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
    Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
    Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    Adamson PC; Lin EY; Ha SM; Klausner JD
    J Antimicrob Chemother; 2021 Oct; 76(11):2847-2849. PubMed ID: 34324655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting.
    Bailey AL; Potter RF; Wallace MA; Johnson C; Dantas G; Burnham CA
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31341071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonococcal resistance to zoliflodacin could emerge via transformation from commensal Neisseria species. An in-vitro transformation study.
    Abdellati S; Laumen JGE; de Block T; De Baetselier I; Van Den Bossche D; Van Dijck C; Manoharan-Basil SS; Kenyon C
    Sci Rep; 2024 Jan; 14(1):1179. PubMed ID: 38216602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance and mutation patterns in gyrA and parC genes in Neisseria gonorrhoeae isolates from Shanghai, China.
    Zhang T; Zhou X; Chen Y; Gu W; Zhang T; Jiang Q
    J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):29-34. PubMed ID: 19224158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.